Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
NCT ID: NCT00067535
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
16 participants
INTERVENTIONAL
2003-06-30
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
NCT00032916
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275
Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
NCT02537873
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315
Improving Learning-based Treatment of Cocaine Dependence With Medication
NCT01526538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
TRIPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cocaine-Related Disorders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-treatment seekers
* DSM-IV criteria for cocaine abuse or dependence
* Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements
Exclusion Criteria
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louis Cantilena, M.D.
Role: PRINCIPAL_INVESTIGATOR
Uniformed Services University of Health Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uniformed Services University of Health Science
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-CPU-0003-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.